Notably, JIA was the predominant diagnosis in both the overall control group and ANA-positive subset, with 42.4% demonstrating musculoskeletal involvement-the sole criterion showing statistically significant intergroup differences, albeit lower in the SLE group. The gene discussed is BTG3; the disease is systemic lupus erythematosus.